These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3484506)

  • 21. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
    Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
    J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
    Townsend K; Ladhani SN; Findlow H; Borrow R
    Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine.
    Barington T; Heilmann C; Andersen V
    Scand J Immunol; 1990 Apr; 31(4):515-22. PubMed ID: 2185534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biology of Haemophilus influenzae type b vaccination failure.
    Holmes SJ; Granoff DM
    J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.
    Hetherington SV; Patrick CC
    Infect Immun; 1992 Jan; 60(1):19-24. PubMed ID: 1729183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B.
    Insel RA; Anderson PW
    J Immunol; 1982 Mar; 128(3):1267-70. PubMed ID: 7035561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Shackelford PG; Granoff DM; Nelson SJ; Scott MG; Smith DS; Nahm MH
    J Immunol; 1987 Jan; 138(2):587-92. PubMed ID: 3491852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. II. Antibodies subclasses.
    Zarei AE; Redwan EM
    Hum Antibodies; 2019; 27(1):1-11. PubMed ID: 30103308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Gilsdorf JR; McDonnell WM
    Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
    Ambrosino DM; Schiffman G; Gotschlich EC; Schur PH; Rosenberg GA; DeLange GG; van Loghem E; Siber GR
    J Clin Invest; 1985 Jun; 75(6):1935-42. PubMed ID: 3924957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide.
    Nahm MH; Kim KH; Anderson P; Hetherington SV; Park MK
    Infect Immun; 1995 Aug; 63(8):2989-94. PubMed ID: 7622221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from infection with Haemophilus influenzae type b by monoclonal antibody to the capsule.
    Gigliotti F; Insel RA
    J Infect Dis; 1982 Aug; 146(2):249-54. PubMed ID: 6980957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory.
    Granoff DM; Lucas AH
    Ann N Y Acad Sci; 1995 May; 754():278-88. PubMed ID: 7625664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen.
    Chung GH; Scott MG; Kim KH; Kearney J; Siber GR; Ambrosino DM; Nahm MH
    J Immunol; 1993 Oct; 151(8):4352-61. PubMed ID: 8409407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
    J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.
    Ambrosino DM; Umetsu DT; Siber GR; Howie G; Goularte TA; Michaels R; Martin P; Schur PH; Noyes J; Schiffman G
    J Allergy Clin Immunol; 1988 Jun; 81(6):1175-9. PubMed ID: 3259962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.
    Nix EB; Choi J; Anthes C; Gaultier GN; Thorgrimson J; Cox AD; Tsang RSW; McCready WG; Boreham D; Ulanova M
    PLoS One; 2018; 13(8):e0201282. PubMed ID: 30110339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.